Results 111 to 120 of about 6,645 (179)

Congenital Malformations of the Central Nervous System Caused by Bluetongue Virus Serotype 3 (BTV-3) in Two Calves. [PDF]

Vet Sci
Duc PD, Reeh S, Pöpperl P, Schreiner T, Gundling N, Beineke A, Wohlsein P, Hoedemaker M.   +7 more
europepmc   +1 more source

Insect-borne non-enveloped bluetongue virus utilizes discrete small vesicles for non-lytic release and cell-to-cell transmission. [PDF]

PLoS Pathog
Wu W, Laugks U, Grünewald K, Roy P.
europepmc   +1 more source

National Seroprevalence and Risk Factors of Bluetongue Virus in Domestic Ruminants of Peru. [PDF]

Transbound Emerg Dis
Navarro-Mamani DA, Jurado J, Vargas-Calla A, Ponce K, Sherman T, Zarate Y, Murga-Moreno CA, Perez I, Villacaqui R, Ara M, Ortiz P, Rivera H, Mayo CE.   +12 more
europepmc   +1 more source

Biomimetic Apatite Nanoparticles and Microcrystalline Tyrosine as Biocompatible Vaccine Adjuvants: Performance in a Bluetongue Virus Sheep Model. [PDF]

ACS Appl Mater Interfaces
Pérez E, Sebastián V, Rodríguez-Largo A, de Miguel R, Gómez Á, Kramer MF, Graessel A, Parra-Torrejón B, Delgado-López JM, Utrilla-Trigo S, Jiménez-Cabello L, Ortego J, de Blas I, Reina R, Pérez M, Luján L.   +15 more
europepmc   +1 more source

The effect of pH on the structure of Bluetongue virus VP5. [PDF]

J Gen Virol
Zhang H, El Omari K, Sutton G, Stuart DI.   +3 more
europepmc   +1 more source

Linking vector favourable environmental conditions with serological evidence of widespread bluetongue virus exposure in livestock in Ecuador. [PDF]

Sci Rep
Acosta A, Barrera M, Jarrín D, Maldonado A, Salas J, Camargo G, Mello B, Burbano A, DelaTorre E, Hoffman B, Dietze K.   +10 more
europepmc   +1 more source

Clinical disease in British sheep infected with an emerging strain of bluetongue virus serotype 3. [PDF]

Vet Rec
Newbrook K, Obishakin E, Jones LA, Waters R, Ashby M, Batten C, Sanders C.   +6 more
europepmc   +1 more source

The MVA-VP2-NS1-2A-NS2-Nt vaccine candidate provides heterologous protection in sheep against bluetongue virus. [PDF]

Front Immunol
Jiménez-Cabello L, Utrilla-Trigo S, Illescas-Amo M, Rodríguez-Sabando K, Benavides-Silván J, Calvo-Pinilla E, Ortego J.   +6 more
europepmc   +1 more source

Development and Evaluation of a Candidate Inactivated Vaccine Against Bluetongue Virus Serotype 4 (BTV4). [PDF]

Vaccines (Basel)
Veljovic L, Glisic D, Kirovski M, Paušak L, Milicevic V.   +4 more
europepmc   +1 more source

First Detection of Bluetongue Virus Type 3 in Poland in 2024-A Case Study in European Bison (<i>Bison bonasus</i>). [PDF]

Pathogens
Larska M, Orłowska A, Łopuszyński W, Skurka Ł, Nowakowska A, Trębas P, Krzysiak MK, Rola J, Smreczak M.   +8 more
europepmc   +1 more source